The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.00
Bid: 141.00
Ask: 143.50
Change: -2.25 (-1.56%)
Spread: 2.50 (1.773%)
Open: 144.00
High: 144.00
Low: 142.00
Prev. Close: 144.50
RCN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close Trading Update

31 Mar 2014 07:00

RNS Number : 5433D
Redcentric PLC
31 March 2014
 



31 March 2014

 

Redcentric plc

 

("Redcentric" or "the Group")

 

Pre-close Trading Update

 

Redcentric plc (AIM:RCN), a leading UK IT managed services provider announces a pre-close trading update. The Group expects to report its preliminary results for the financial year ended 31 March 2014 on 16 June 2014. 

Summary

· Trading comfortably in line with market expectations

· Recent contract wins and pipeline underpin positive outlook for FY 2015

· Strong Q4 cash flow

· Integration of inTechnology is on plan

· Intention to pay maiden dividend re-affirmed

Trading

Trading across the Group has continued to be in line with the Board's expectations and consequently Redcentric expects its results for the year ended 31 March 2014 to be comfortably in line with market expectations. The Group enters its new financial year with a good pipeline of new business opportunities underpinned by recent contract wins.

The Board has been pleased to see sustained improvements in operating cash flow conversion from the first half of the year following the expected unwind of working capital in the Redcentric business. Redcentric currently anticipates that net debt at the year-end will be in the region of £12.5 million and is expected to reduce significantly during 2014.

Integration

Redcentric remains on target to realise the synergies anticipated at the time of the acquisition of inTechnology Managed Services ("inTechnology"). The integration of the two businesses is progressing as planned as the Group seeks to combine all of its operations. A group operating board has been established across Sales, Operations and Finance and the integration programme will continue through FY2015 although the accounting and billing functions should be unified within the first half of the year.

Dividend

The Group reaffirms its intention to declare a maiden dividend with its results for the year ended 31 March 2014 marking the start of a progressive dividend policy.

Outlook

The acquisition of inTechnology is delivering the benefits that we expected. An encouraging pipeline and recent contract wins underpin organic growth which allied to a very strong base of contracted revenues puts the Group in a solid position to continue to deliver attractive shareholder returns.

 

Enquiries:

Redcentric plc Tel. +44 (0)845 034 1111

Tony Weaver, Chief Executive

Fraser Fisher, Chief Operating Officer

Tim Coleman, Chief Financial Officer

N+1 Singer - Nomad & Joint Broker Tel: +44 (0)20 7496 3000

Jonny Franklin-Adams / Ben Wright

 

finnCap - Joint Broker Tel: +44 (0)20 7220 0500

Charlotte Stranner / Stuart Andrews

 

MXC Capital Advisory LLP - Corporate Finance Adviser

Marc Young Tel. +44 (0)20 7965 8149

 

Newgate Threadneedle - Financial PR Tel. +44 (0)20 7653 9850

Josh Royston / Hilary Millar

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTWGUCCWUPCURU
Date   Source Headline
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSHalf Year Results
20th Oct 20231:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSExercise of Options
3rd Oct 20237:00 amRNSSave As You Earn Share Option Scheme
28th Sep 20234:00 pmRNSResult of AGM
20th Sep 20234:08 pmRNSGrant of Options and Director/PDMR Shareholding
4th Sep 20237:00 amRNSPublication of Annual Report and Notice of AGM
24th Aug 20237:00 amRNSPreliminary results announcement FY23
17th Aug 20237:00 amRNSNotice of Results
17th Jul 20237:00 amRNSUpdate on Annual Results
28th Apr 20235:08 pmRNSHolding(s) in Company
25th Apr 20237:01 amRNSDirectorate Change
25th Apr 20237:00 amRNSTrading Update
31st Mar 20233:14 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSExercise of Options
8th Feb 20237:00 amRNSExercise of Options
11th Jan 20237:00 amRNSExercise of Options
30th Dec 20227:00 amRNSExercise of Options
12th Dec 20227:00 amRNSExercise of Options
8th Dec 20227:00 amRNSHalf Year Results
29th Nov 20223:09 pmRNSHolding(s) in Company
17th Nov 20222:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.